Metlife Inc (NYSE: MET) has a price-to-earnings ratio of 19.07x that is above its average ratio. Additionally, the 36-month beta value for MET is 1.05. There are mixed opinions on the stock, with 6 analysts rating it as a “buy,” 3 rating it as “overweight,” 6 rating it as “hold,” and 0 rating it as “sell.”
The public float for MET is 586.57M and currently, short sellers hold a 1.35% ratio of that float. The average trading volume of MET on August 12, 2024 was 3.11M shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
MET) stock’s latest price update
The stock price of Metlife Inc (NYSE: MET) has jumped by 0.72 compared to previous close of 70.13. Despite this, the company has seen a gain of 3.94% in its stock price over the last five trading days. forbes.com reported 2024-08-12 that MetLife’s stock (NYSE: MET) has gained 6% YTD as compared to the 10% rise in the S&P500 index over the same period. Notably, MetLife’s peer Prudential Financial (NYSE: PRU) is up 5% YTD.
MET’s Market Performance
MET’s stock has risen by 3.94% in the past week, with a monthly drop of -3.75% and a quarterly drop of -2.88%. The volatility ratio for the week is 2.01% while the volatility levels for the last 30 days are 2.19% for Metlife Inc The simple moving average for the past 20 days is -4.10% for MET’s stock, with a 2.26% simple moving average for the past 200 days.
Analysts’ Opinion of MET
Many brokerage firms have already submitted their reports for MET stocks, with Goldman repeating the rating for MET by listing it as a “Buy.” The predicted price for MET in the upcoming period, according to Goldman is $80 based on the research report published on January 08, 2024 of the current year 2024.
Barclays, on the other hand, stated in their research note that they expect to see MET reach a price target of $71. The rating they have provided for MET stocks is “Overweight” according to the report published on November 17th, 2023.
Deutsche Bank gave a rating of “Hold” to MET, setting the target price at $71 in the report published on October 05th of the previous year.
MET Trading at -1.56% from the 50-Day Moving Average
After a stumble in the market that brought MET to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -10.97% of loss for the given period.
Volatility was left at 2.19%, however, over the last 30 days, the volatility rate increased by 2.01%, as shares sank -5.44% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -1.03% lower at present.
During the last 5 trading sessions, MET rose by +3.56%, which changed the moving average for the period of 200-days by +18.87% in comparison to the 20-day moving average, which settled at $73.46. In addition, Metlife Inc saw 6.82% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at MET starting from PAPPAS BILL, who sale 27,000 shares at the price of $72.27 back on Mar 18 ’24. After this action, PAPPAS BILL now owns 57,768 shares of Metlife Inc, valued at $1,951,325 using the latest closing price.
TADROS RAMY, the President, U.S. Business of Metlife Inc, sale 4,026 shares at $71.90 during a trade that took place back on Mar 13 ’24, which means that TADROS RAMY is holding 146,981 shares at $289,479 based on the most recent closing price.
Stock Fundamentals for MET
Current profitability levels for the company are sitting at:
- 0.04 for the present operating margin
- 1.0 for the gross margin
The net margin for Metlife Inc stands at 0.04. The total capital return value is set at 0.0. Equity return is now at value 10.12, with 0.43 for asset returns.
Based on Metlife Inc (MET), the company’s capital structure generated 0.41 points at debt to capital in total, while cash flow to debt ratio is standing at 0.77. The debt to equity ratio resting at 0.69. The interest coverage ratio of the stock is 2.81.
Currently, EBITDA for the company is 2.36 billion with net debt to EBITDA at -0.63. When we switch over and look at the enterprise to sales, we see a ratio of 0.69. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.97.
Conclusion
In conclusion, Metlife Inc (MET) has seen mixed performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
